ArticleOpen forum infectious diseases2025
Economic Burden of TB Deaths in India (2021): A Retrospective Cross-sectional Study.
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We aimed to estimat the economic burden of TB deaths in terms of gross domestic product (GDP) across Indian states, regions, and different demographic groups. Methodology: Using the Human Capital Approach, we estimated the non-health GDP losses due to TB deaths in India for 2021 at subnational level. The total monetary value for the years of life lost due to TB deaths was calculated. Results: In 2021, 0.393 million TB deaths occurred in India, which would reduce the non-health GDP by US$9.1 billion. North, West, South, and North Eastern states of India incurred 33.5%, 25.6%, 18.5%, and 9.3% of that economic loss respectively. Each TB death resulted in non-health GDP loss of US$23 161. The economic burden was highest among youngr males (20.5%) followed by males aged >75 years (17.3%). The economic cost was minimal among male adolescents and youth accounting for 3.4%. Conclusions: Finndings underscore the urgent need for concerted multisectoral efforts, sustained investments and strategies to reduce TB deaths, and mitigate the resulting economic losses at sub-national level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.